arrow
Back
P

Paul Lorigan

University of Manchester

87H-index
683Paper Count
6.3WCitation Count
Published Papers 212
Publication Date
Overall survival according to timing of immune checkpoint inhibitors administration in patients with advanced cancer: results from a large single-centre cohort analysis
err2026-07-18
err0
errOAAI
errTommaso Bosetti; Oliver John Kennedy; Raffaele Califano; Tom Waddell; Rob Metcalf; Sophia Kreft; Rebecca Lee; Paul Lorigan
errShare
errSave
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years
err2026-07-02
err0
errOAAI
errClaus Garbe; Ulrike Keim; Teresa Amaral; Paolo A. Ascierto; Jürgen Bauer; Reinhard Dummer; Alexander M. M. Eggermont; Thomas K. Eigentler; Lukas Flatz; Stephan Forchhammer; Andrea Forschner; Sara Gandini; Jeffrey E. Gershenwald; Axel Hauschild; Christoph Hoeller; John M. Kirkwood; Celeste Lebbe; Georgina V. Long; Paul Lorigan; Jason J. Luke; Friedegund Meier; Gisela Metzler; Paul Nathan; Michael A. Postow; Caroline Robert; Martin Röcken; Dirk Schadendorf; Benjamin Weide; David Whiteman; Ulrike Leiter; Peter Martus
errShare
errSave
Bowel cancer care in individuals with an intellectual disability: a population-based cohort study of symptoms, diagnostic pathways, treatment and survival
err2026-05-20
err0
errOAAI
errOliver John Kennedy; Umesh Chauhan; Louise Gorman; Paul Lorigan; Samuel W. D. Merriel; Antonia Perumal; Tjeerd Van Staa; Alison Wright; Darren Mark Ashcroft
errShare
errSave
Hepatitis at Home: Ambulatory management of severe immune checkpoint inhibitor related hepatitis
err2026-05-19
err0
PREAI
errTim Cooksley; Jamie MJ Weaver; Safwaan Adam; Tomasso Bosetti; Thomas Knight; Daniel Lasserson; Rebecca Lee; Paul Lorigan
errShare
errSave
Tumour-infiltrating lymphocyte therapy in melanoma: ready for prime time?
err2026-02-18
err0
errOAAI
errRachel Woodford; Paul Lorigan; Deemesh Oudit; Ahmed Abdulgawad; Fiona Thistlethwaite; Kok Haw Jonathan Lim
errShare
errSave
The telomerase vaccine UV1 combined with ipilimumab and nivolumab versus ipilimumab and nivolumab in advanced melanoma (INITIUM): a randomized open-label phase 2 study
err2025-12-03
err0
PREAI
errPaul Lorigan; Theresa Michelle Medina; Marta Nyakas; Annemie Rutten; Lynn G. Feun; Charles Lance Cowey; Miranda Payne; Israr Hussain; Timothy Kuzel; Steven O’Day; Amna Sheri; Philip Adam Friedlander; Satish Kumar; Vanja Sue Bergersen; Øivind Foss; Espen Basmo Ellingsen; Jens Bjørheim; Oliver Edgar Bechter
errShare
errSave
Cancer diagnoses, referrals, and survival in people with a learning disability in the UK: a population-based, matched cohort study
err2025-11-14
err0
errOAAI
errOliver John Kennedy; Umesh Chauhan; Louise Gorman; Paul Lorigan; Samuel Merriel; Tjeerd Van Staa; Alison Wright; Darren Mark Ashcroft
errShare
errSave
A national cohort study of melanoma BRAF status, testing patterns, patient and tumour characteristics, treatment and survival in England from 2016 to 2021
err2025-10-01
err1
errOAAI
errMistry, Khaylen; Jeffrey, Polly; Levell, Nick J.; Kennedy, Oliver; Richardson, Kathryn; Craig, Paul; Bright, Chloe; Taylor, Siobhan; Ragan, John; Karponis, Dimitrios; Pethick, Joanna; Lavelle, Katrina; McRonald, Fiona; Hardy, Steven; Vernon, Sally; Lorigan, Paul; Venables, Zoe C.
errShare
errSave
The economic burden of melanoma in the UK: a stage-specific cost analysis underscoring the importance of prevention and early diagnosis
err2025-10-01
err0
errOAAI
errMistry, Khaylen; Bagdatoglou, George; Daniels, Susanna; Lorigan, Paul; Levell, Nick J.; Proby, Charlotte; Venables, Zoe C.
errShare
errSave
Immune-mediated hepatitis requiring second-line immunosuppression: how long is required? An observational study
err2025-09-01
err0
PREAI
errCooksley, Tim; Weaver, Jamie M. J.; Adam, Safwaan; Lasserson, Daniel; Lee, Rebecca; Lorigan, Paul
errShare
errSave
An update on access to novel treatment for metastatic melanoma in Europe - A 2024 survey of the European melanoma registry and the European association of dermato-oncology
err2025-02-01
err1
PREAI
errKandolf, L.; Ascierto, P. A.; Bastholt, L.; Gavrilova, I.; Haanen, J.; Hauschild, A.; Herceg, D.; Hoeller, C.; Suljevic, A. Jalovcic; Kessels, Ji; Krajsova, I.; Kukushkina, M.; Lallas, A.; Lorigan, P.; Mangana, J.; Marquez-Rodas, I.; Mazilu, L.; Mohr, P.; Bylaite-Bucinskiene, M.; Ocvirk, J.; Olah, J.; Putnik, K.; Rutkowski, P.; Saiag, P.; Samolyenko, I.; Schwarze, J. K.; Stojkovski, I.; Saric, N. Cicmil; Vieira, R.; Weichenthal, M.; Garbe, C.
errShare
errSave
Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
err2025-01-01
err11
PREAI
errAmaral, T.; Ottaviano, M.; Arance, A.; Blank, C.; Chiarion-Sileni, V.; Donia, M.; Dummer, R.; Garbe, C.; Gershenwald, J. E.; Gogas, H.; Guckenberger, M.; Haanen, J.; Hamid, O.; Hauschild, A.; Hoeller, C.; Lebbe, C.; Lee, R. J.; Long, G., V; Lorigan, P.; Couselo, E. Munoz; Nathan, P.; Robert, C.; Romano, E.; Schadendorf, D.; Sondak, V; Suijkerbuijk, K. P. M.; van Akkooi, A. C. J.; Michelin, O.; Ascierto, P. A.
errShare
errSave
Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial
err2024-11-01
err2
PREAI
errEggermont, Alexander M. M.; Kicinski, Michal; Blank, Christian U.; Mandala, Mario; V. Long, Georgina; Atkinson, Victoria; Dalle, Stephane; Haydon, Andrew; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Boers-Sonderen, Marye; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus J. M.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; van Akkooi, Alexander C. J.; Lorigan, Paul; Grebennik, Dmitri; Kreplere, Clemens; Marreaud, Sandrine; Suciu, Stefan; Robert, Caroline
errShare
errSave
Systemic immune-inflammation index and overall survival with checkpoint inhibitors
err2024-09-01
err0
PREAI
errKennedy, O.; Ali, N.; Lee, R.; Cooksley, T.; Lorigan, P.
errShare
errSave
Mining nucleic acid omicsto boost liquid biopsy in cancer
err2024-09-01
err1
errOAAI
errTivey, Ann; Lee, Rebecca J.; Clipson, Alexandra; Hill, Steven M.; Lorigan, Paul; Rothwell, Dominic G.; Dive, Caroline; Mouliere, Florent
errShare
errSave
Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastases
err2024-07-01
err1
PREAI
errda Silva, Ines Pires; Li, Isabel; Ugurel, Selma; Serra-Bellver, Patricio; Andhale, Avanti; Burnette, Hannah; Aya, Francisco; Conway, Jordan W.; Braden, Jorja; Carlino, Matteo S.; Menzies, Alexander M.; Weichenthal, Michael; Mohr, Peter; Gutzmer, Ralf; Arance, Ana M.; Johnson, Douglas B.; Lorigan, Paul; Schadendorf, Dirk; Lo, Serigne N.; Long, Georgina V.
errShare
errSave
Thyroid dysfunction after immune checkpoint inhibitors in a single-centre UK pan-cancer cohort: A retrospective study
err2024-05-01
err1
errOAAI
errKennedy, Oliver John; Ali, Nadia; Lee, Rebecca; Monaghan, Phillip; Adam, Safwaan; Cooksley, Tim; Lorigan, Paul
errShare
errSave
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after de fi nitive surgery: a multicenter, retrospective cohort study (vol 65, 102290, 2023)
err2024-05-01
err0
errOAAI
errBai, Xue; Shaheen, Ahmed; Grieco, Charlotte; Arienzo, Paolo D.; Mina, Florentia; Czapla, Juliane A.; Lawless, Aleigha R.; Bongiovanni, Eleonora; Santaniello, Umberto; Zappi, Helena; Dulak, Dominika; Williamson, Andrew; Lee, Rebecca; Gupta, Avinash; Li, Caili; Si, Lu; Ubaldi, Martina; Yamazaki, Naoya; Ogata, Dai; Johnson, Rebecca; Park, Benjamin C.; Jung, Seungyeon; Madonna, Gabriele; Hochherz, Juliane; Umeda, Yoshiyasu; Nakamura, Yasuhiro; Gebhardt, Christoffer; Festino, Lucia; Capone, Mariaelena; Ascierto, Paolo Antonio; Johnson, Douglas B.; Lo, Serigne N.; V. Long, Georgina; Menzies, Alexander M.; Namikawa, Kenjiro; Mandala, Mario; Guo, Jun; Lorigan, Paul; Najjar, Yana G.; Haydon, Andrew; Quaglino, Pietro; Boland, Genevieve M.; Sullivan, Ryan J.; Furness, Andrew J. S.; Plummer, Ruth; Flaherty, Keith T.
errShare
errSave
A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma
err2024-05-01
err2
errOAAI
errSacco, Joseph J.; Jackson, Richard; Corrie, Pippa; Danson, Sarah; Evans, T. R. Jeffry; Ochsenreither, Sebastian; Kumar, Satish; Goodman, Andrew; Larkin, James; Karydis, Ioannis; Steven, Neil; Lorigan, Paul; Plummer, Ruth; Patel, Poulam; Psarelli, Eftychia; Olsson-Brown, Anna; Shaw, Heather; Leyvraz, Serge; Handley, Louise; Rawcliffe, Charlotte; Nathan, Paul
errShare
errSave
Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma*
err2024-04-01
err0
PREAI
errKennedy, Oliver John; Glassee, Nina; Kicinski, Michal; Blank, Christian U.; V. Long, Georgina; Atkinson, Victoria G.; Dalle, Stephane; Haydon, Andrew M.; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Boers-Sonderen, Marye; Giacomo, Anna Maria Di; Eertwegh, Alfonsus J. M. van den; Grob, Jean -Jacques; Gutzmer, Ralf; Jamal, Rahima; Akkooi, Alexander C. J. van; Gandini, Sara; Buhrer, Emanuel; Suciu, Stefan; Robert, Caroline; Eggermont, Alexander M. M.; Mandala, Mario; Lorigan, Paul; Valpione, Sara
errShare
errSave